Smruthi Organics Limited

SMRUTHIORG6

INE172E01011

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:53 2024-04-30 am EDT			5-day change	1st Jan Change
157.6 ^INR	+2.14%		-0.06%	-9.16%

Feb. 03	Smruthi Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
2023	Smruthi Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	CI

Smruthi Organics : Intimation on issue of duplicate share certificates - Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

March 13, 2024 at 02:50 am EDT

Company Name (SYMBOL)	Smruthi Organics Limited ( SMRUTHI )
Subject	Intimation on issue of duplicate share certificates - Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Brief Details	Intimation on issue of duplicate share certificates - Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Attachment	13032024_SMRUTHI_01.pdf

Attachments

Original Link
Permalink

Disclaimer

Smruthi Organics Ltd. published this content on 13 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 March 2024 06:49:06 UTC.

Latest news about Smruthi Organics Limited

Smruthi Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 03	CI
Smruthi Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09	CI
Smruthi Organics Limited Approves Dividend for the Year Ended 31 March 2023	23-08-05	CI
Smruthi Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-05	CI
Smruthi Organics Limited Proposes Dividend for the Year Ended 31St March, 2023	23-07-12	CI
Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-20	CI
Smruthi Organics Limited Announces Dividend for the Fiscal Year 2022-2023	23-05-20	CI
Smruthi Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-09	CI
Smruthi Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI
Smruthi Organics Limited Approves the Dividend for the Year Ended March 31, 2022	22-08-08	CI
Smruthi Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-06	CI
Smruthi Organics Limited Recommends Dividend	22-05-28	CI
Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	22-05-28	CI
Smruthi Organics Limited Approves Board Changes	22-02-12	CI
Smruthi Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-12	CI
Smruthi Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-13	CI
Smruthi Organics' : Net Profit Slides in Fiscal Q1	21-07-16	MT
Smruthi Organics Limited Declares Dividend for the Year Ended 31 March 2021	21-07-16	CI
Smruthi Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	21-07-16	CI
Smruthi Organics Limited Recommends Dividend, Payable on or Before August 14, 2021	21-06-09	CI
Smruthi Organics Limited Recommends Dividend for the Year Ended March 31, 2021	21-04-23	CI
Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-04-23	CI
Smruthi Organics Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	21-01-16	CI
Smruthi Organics Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	20-10-19	CI
Smruthi Organics Limited Approves Dividend	20-09-11	CI

Chart Smruthi Organics Limited

Duration

Period

More charts

Company Profile

Smruthi Organics Limited is an India-based active pharmaceutical ingredients (API) manufacturer serving pharmaceutical companies. The Companyâs segments include Bulk Drugs and Drugs Intermediates and Formulation. It manufactures API products in the anti-diabetic, anti-hypertension and anti-infectives therapeutic categories. Its products include Amlodipine Besilate, Losartan Potassium, Telmisartan, Metformin HCL, S-Amlodipine Besilate, S-Amlodipine Malelate, Valsartan, Vildagliptin, Teneligliptin, Ciprofloxacin HCL, Diloxanide Furoate, Norfloxacin, Pefloxacin Mesylate, Ticagrelor, and others. It caters to both the Indian domestic as well as the rest of the world (ROW) markets, with clients spanning Asia, the Americas, and Africa. The Company has two manufacturing facilities in Solapur, India. The API facility is spread across 22-acre land.

Sector

Pharmaceuticals

Calendar

2024-05-19 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SMRUTHI ORGANICS LIMITED	-9.16%	21.16M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.27%	43.75B
OTSUKA HOLDINGS CO., LTD.	+27.47%	22.06B
SANDOZ GROUP AG	+15.11%	14.46B
CIPLA LIMITED	+12.33%	13.62B
ZYDUS LIFESCIENCES LIMITED	+38.36%	11.61B
ONO PHARMACEUTICAL CO., LTD.	-9.54%	6.9B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+10.21%	5.32B